Protein Kinase C is Activated in Glomeruli from Streptozotocin Diabetic Rats. Possible Mediation by Glucose

Overview

Journal J Clin Invest

Specialty General Medicine

Date 1989 May 1

PMID 2708528

Citations 51

Authors

P A Craven

F R Derubertis

Affiliations

Soon will be listed here.

Abstract

Glomerular inositol content and the turnover of polyphosphoinositides was reduced by 58% in 1-2 wk streptozotocin diabetic rats. Addition of inositol to the incubation medium increased polyphosphoinositide turnover in glomeruli from diabetic rats to control values. Despite the reduction in inositol content and polyphosphoinositide turnover, protein kinase C was activated in glomeruli from diabetic rats, as assessed by an increase in the percentage of enzyme activity associated with the particulate cell fraction. Total protein kinase C activity was not different between glomeruli from control and diabetic rats. Treatment of diabetic rats with insulin to achieve near euglycemia prevented the increase in particulate protein kinase C. Moreover, incubation of glomeruli from control rats with glucose (100-1,000 mg/dl) resulted in a progressive increase in labeled diacylglycerol production and in the percentage of protein kinase C activity which was associated with the particulate fraction. These results support a role for hyperglycemia per se in the enhanced state of activation of protein kinase C seen in glomeruli from diabetic rats. Glucose did not appear to increase diacylglycerol by stimulating inositol phospholipid hydrolysis in glomeruli. Other pathways for diacylglycerol production, including de novo synthesis and phospholipase C mediated hydrolysis of phosphatidylcholine or phosphatidyl-inositol-glycan are not excluded.

Citing Articles

A protein kinase C α and β inhibitor blunts hyperphagia to halt renal function decline and reduces adiposity in a rat model of obesity-driven type 2 diabetes.

Wang J, Casimiro-Garcia A, Johnson B, Duffen J, Cain M, Savary L Sci Rep. 2023; 13(1):16919.

PMID: 37805649 PMC: 10560236. DOI: 10.1038/s41598-023-43759-7.

Cellular mechanism of action of forsythiaside for the treatment of diabetic kidney disease.

Xu C, Miao H, Chen X, Zhang H Front Pharmacol. 2023; 13:1096536.

PMID: 36712665 PMC: 9880420. DOI: 10.3389/fphar.2022.1096536.

The Role of Diacylglycerol Kinase in the Amelioration of Diabetic Nephropathy.

Hayashi D, Shirai Y Molecules. 2022; 27(20).

PMID: 36296376 PMC: 9607625. DOI: 10.3390/molecules27206784.

Immunity and inflammation in diabetic kidney disease: translating mechanisms to biomarkers and treatment targets.

Pichler R, Afkarian M, Dieter B, Tuttle K Am J Physiol Renal Physiol. 2016; 312(4):F716-F731.

PMID: 27558558 PMC: 6109808. DOI: 10.1152/ajprenal.00314.2016.

Evaluation of Protein Kinase Cβ and PPARγ Activity in Diabetic Rats Supplemented with Momordica charantia.

Chandru S, Vishwanath P, Devegowda D, Ramasamudra S, Prashant A, Hathur B J Clin Diagn Res. 2016; 10(4):BF01-4.

PMID: 27190792 PMC: 4866090. DOI: 10.7860/JCDR/2016/18161.7653.

References

Gillon K, HAWTHORNE J . Transport of myo-inositol into endoneurial preparations of sciatic nerve from normal and streptozotocin-diabetic rats. Biochem J. 1983; 210(3):775-81. PMC: 1154289. DOI: 10.1042/bj2100775. View

Kirschenbaum M, Chaudhari A . Effect of experimental diabetes on glomerular filtration rate and glomerular prostanoid production in the rat. Miner Electrolyte Metab. 1986; 12(5-6):352-5. View

Gillon K, HAWTHORNE J, Tomlinson D . Myo-inositol and sorbitol metabolism in relation to peripheral nerve function in experimental diabetes in the rat: the effect of aldose reductase inhibition. Diabetologia. 1983; 25(4):365-71. DOI: 10.1007/BF00253203. View

Irvine R, Letcher A, Dawson R . Phosphatidylinositol-4,5-bisphosphate phosphodiesterase and phosphomonoesterase activities of rat brain. Some properties and possible control mechanisms. Biochem J. 1984; 218(1):177-85. PMC: 1153322. DOI: 10.1042/bj2180177. View

Ku L, Cohen M . Glomerular polyol accumulation in diabetes and its prevention by oral sorbinil. Diabetes. 1984; 33(6):604-7. DOI: 10.2337/diab.33.6.604. View

Dunlop M, Larkins R . Activity of endogenous phospholipase C and phospholipase A2 in glucose stimulated pancreatic islets. Biochem Biophys Res Commun. 1984; 120(3):820-7. DOI: 10.1016/s0006-291x(84)80180-1. View

Farese R, Farese Jr R, Sabir M, Larson R, Trudeau 3rd W, Barnes D . The mechanism of action of insulin on phospholipid metabolism in rat adipose tissue. Requirement for protein synthesis and a carbohydrate source, and relationship to activation of pyruvate dehydrogenase. Diabetes. 1984; 33(7):648-55. DOI: 10.2337/diab.33.7.648. View

Schambelan M, Blake S, Sraer J, Bens M, Nivez M, Wahbe F . Increased prostaglandin production by glomeruli isolated from rats with streptozotocin-induced diabetes mellitus. J Clin Invest. 1985; 75(2):404-12. PMC: 423505. DOI: 10.1172/JCI111714. View

Dethy J, Janssens M, LENAERS A . Determination of sorbitol and galactitol at the nanogram level in biological samples by high-performance liquid chromatography. Anal Biochem. 1984; 143(1):119-24. DOI: 10.1016/0003-2697(84)90565-7. View

10.

Kreutter D, CALDWELL A, MORIN M . Dissociation of protein kinase C activation from phorbol ester-induced maturation of HL-60 leukemia cells. J Biol Chem. 1985; 260(10):5979-84. View

11.

Esmatjes E, Fernandez M, Halperin I, Camps J, Gaya J, Arroyo V . Renal hemodynamic abnormalities in patients with short term insulin-dependent diabetes mellitus: role of renal prostaglandins. J Clin Endocrinol Metab. 1985; 60(6):1231-6. DOI: 10.1210/jcem-60-6-1231. View

12.

Anderson W, Estival A, Tapiovaara H, Gopalakrishna R . Altered subcellular distribution of protein kinase C (a phorbol ester receptor). Possible role in tumor promotion and the regulation of cell growth: relationship to changes in adenylate cyclase activity. Adv Cyclic Nucleotide Protein Phosphorylation Res. 1985; 19:287-306. View

13.

Cohen M, Klepser H . Binding of an aldose reductase inhibitor to renal glomeruli. Biochem Biophys Res Commun. 1985; 129(2):530-5. DOI: 10.1016/0006-291x(85)90184-6. View

14.

Ballester R, Rosen O . Fate of immunoprecipitable protein kinase C in GH3 cells treated with phorbol 12-myristate 13-acetate. J Biol Chem. 1985; 260(28):15194-9. View

15.

Greene D, Lattimer S . Protein kinase C agonists acutely normalize decreased ouabain-inhibitable respiration in diabetic rabbit nerve. Implications for (Na,K)-ATPase regulation and diabetic complications. Diabetes. 1986; 35(2):242-5. DOI: 10.2337/diab.35.2.242. View

16.

Farese R, DiMarco P, Barnes D, Sabir M, Larson R, Davis J . Rapid glucose-dependent increases in phosphatidic acid and phosphoinositides in rat pancreatic islets. Endocrinology. 1986; 118(4):1498-503. DOI: 10.1210/endo-118-4-1498. View

17.

Beyer T, Hutson N . Introduction: evidence for the role of the polyol pathway in the pathophysiology of diabetic complications. Metabolism. 1986; 35(4 Suppl 1):1-3. DOI: 10.1016/0026-0495(86)90178-2. View

18.

. The polyol pathway, sorbinil, and renal dysfunction. Metabolism. 1986; 35(4 Suppl 1):46-54. DOI: 10.1016/0026-0495(86)90187-3. View

19.

Cohen M . Aldose reductase, glomerular metabolism, and diabetic nephropathy. Metabolism. 1986; 35(4 Suppl 1):55-9. DOI: 10.1016/0026-0495(86)90188-5. View

20.

Jensen P, Steven K, Blaehr H, Christiansen J, Parving H . Effects of indomethacin on glomerular hemodynamics in experimental diabetes. Kidney Int. 1986; 29(2):490-5. DOI: 10.1038/ki.1986.26. View